Thomas Ryll Immuno Gen, Inc. (IMGN) insider trading activity
Thomas Ryll is SVP, Technical Operations of ImmunoGen, Inc.. Currently has a direct ownership of 84,714 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2021, when has been sold 3,849 shares (Common Stock) at a price of $5.52 per share, resulting in proceeds of $21,246. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
84.7K
0%
3M change
0%
12M change
Total Value Held
$0
TR
Thomas Ryll
SVP, Technical Operations
Waltham, MA